Livanova Plc Share Price (NASDAQ: LIVN)

$53.74

▲

-0.39

(-0.72%)

Last updated on August 16, 2025 at 1:29 AM IST

$₹

Check the interactive Livanova Plc Stock chart to analyse performance

Livanova Plc stock performance

as on August 16, 2025 at 1:29 AM IST

Today's Low:$53.68
Today's High:$54.25
$53.74
0.11%
Downside
Day's Volatility :1.04%
Upside
0.93%
52 Weeks Low:$32.48
52 Weeks High:$57.35
$53.74
39.56%
Downside
52 Weeks Volatility :43.37%
Upside
6.29%

Livanova Plc Stock Returns

Period	Livanova Plc	Sector (Health Care)	Index (Russel 2000)
3 Months	23.13%	2.7%	0.0%
6 Months	14.68%	-7.5%	0.0%
1 Year	17.59%	-12.3%	0.0%
3 Years	-14.5%	-0.3%	-12.5%

Livanova Plc Key Stats

Check Livanova Plc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$54.13
Open	$54.28
Today's High	$54.245
Today's Low	$53.68
Market Capitalization	$2.9B
Today's Volume	$883.8K
52 Week High	$57.3498
52 Week Low	$32.48
Revenue TTM	$1.3B
EBITDA	$246.5M
Earnings Per Share (EPS)	$-3.88
Profit Margin	-16.14%
Quarterly Earnings Growth YOY	0.66%
Return On Equity TTM	-17.87%

Stock Returns calculator for Livanova Plc Stock including INR - Dollar returns

The Livanova Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Livanova Plc investment value today

Current value as on today

₹1,20,374

Returns

₹20,374

(+20.37%)

Returns from Livanova Plc Stock

₹16,119 (+16.12%)

Dollar Returns*

₹4,255 (+4.26%)

Indian investors sentiment towards Livanova Plc Stock

33%

Period: Jul 16, 2025 to Aug 15, 2025. Change in 30 Days versus previous period

Search interest for Livanova Plc Stock from India on INDmoney has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Livanova Plc

Name
Holdings %
Name
Holdings %
BlackRock Inc
13.39%
PRIMECAP Management Company
8.44%
Vanguard Group Inc
4.88%
State Street Corp
3.84%
Capital Research Global Investors
3.81%
Millennium Management LLC
3.78%

Analyst Recommendation on Livanova Plc Stock

Rating

Trend

Buy

73%Buy

26%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Livanova Plc(by analysts ranked 0 to 5 stars)

Livanova Plc Share Price Target

What analysts predicted

Upside of 20.39%

Target:

$64.70

Current:

$53.74

Livanova Plc share price target is $64.70, a slight Upside of 20.39% compared to current price of $53.74 as per analysts' prediction.

Livanova Plc Stock Insights

Price Movement
In the last 7 days, LIVN stock has moved up by 10.9%
Increasing Revenue
Revenue is up for the last 2 quarters, 316.85M → 352.52M (in $), with an average increase of 10.1% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -327.32M → 27.16M (in $), with an average increase of 1305.1% per quarter
LIVN vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 34.3% return, outperforming this stock by 17.3%
LIVN vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 147.1% return, outperforming this stock by 164.5%
Price to Sales
ForLIVN every $1 of sales, investors are willing to pay $2.2, whereas for Boston Scientific Corp., the investors are paying $8.2 for every $1 of sales.

Livanova Plc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$1.1B	↓ 2.06%
Net Income	$-155.5M	↓ 17.9%
Net Profit Margin	-14.34%	↑ 2.77%

	FY20	Y/Y Change
Revenue	$934.2M	↓ 13.84%
Net Income	$-343.3M	↑ 120.77%
Net Profit Margin	-36.75%	↓ 22.41%

	FY21	Y/Y Change
Revenue	$1.0B	↑ 10.83%
Net Income	$-135.7M	↓ 60.47%
Net Profit Margin	-13.11%	↑ 23.64%

	FY22	Y/Y Change
Revenue	$1.0B	↓ 1.31%
Net Income	$-86.2M	↓ 36.48%
Net Profit Margin	-8.44%	↑ 4.67%

	FY23	Y/Y Change
Revenue	$1.2B	↑ 12.89%
Net Income	$17.5M	↓ 120.35%
Net Profit Margin	1.52%	↑ 9.96%

	FY24	Y/Y Change
Revenue	$1.3B	↑ 8.66%
Net Income	$63.2M	↑ 260.39%
Net Profit Margin	5.04%	↑ 3.52%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$294.9M	↓ 4.9%
Net Income	$-41.9M	↓ 356.7%
Net Profit Margin	-14.22%	↓ 19.49%

	Q2 FY24	Q/Q Change
Revenue	$318.6M	↑ 8.02%
Net Income	$16.3M	↓ 138.94%
Net Profit Margin	5.13%	↑ 19.35%

	Q3 FY24	Q/Q Change
Revenue	$318.1M	↓ 0.14%
Net Income	$33.0M	↑ 101.76%
Net Profit Margin	10.36%	↑ 5.23%

	Q4 FY24	Q/Q Change
Revenue	$321.8M	↑ 1.16%
Net Income	$55.9M	↑ 69.61%
Net Profit Margin	17.37%	↑ 7.01%

	Q1 FY25	Q/Q Change
Revenue	$316.9M	↓ 1.54%
Net Income	$-327.3M	↓ 685.64%
Net Profit Margin	-103.3%	↓ 120.67%

	Q2 FY25	Q/Q Change
Revenue	$352.5M	↑ 11.26%
Net Income	$27.2M	↓ 108.3%
Net Profit Margin	7.7%	↑ 111.0%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$744.8M	↑ 1.4%

	FY20	Y/Y Change
Profit	$618.2M	↓ 17.0%

	FY21	Y/Y Change
Profit	$706.0M	↑ 14.2%

	FY22	Y/Y Change
Profit	$707.2M	↑ 0.17%

	FY23	Y/Y Change
Profit	$771.3M	↑ 9.06%

	FY24	Y/Y Change
Profit	$870.9M	↑ 12.92%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$210.6M	↑ 10.72%

	Q2 FY24	Q/Q Change
Profit	$220.4M	↑ 4.64%

	Q3 FY24	Q/Q Change
Profit	$225.3M	↑ 2.22%

	Q4 FY24	Q/Q Change
Profit	$219.3M	↓ 2.65%

	Q1 FY25	Q/Q Change
Profit	$220.8M	↑ 0.67%

	Q2 FY25	Q/Q Change
Profit	$239.0M	↑ 8.25%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-91.1M	↓ 175.6%
Investing Cash Flow	$-41.3M	↓ 65.75%
Financing Cash Flow	$146.6M	↓ 446.57%

	FY20	Y/Y Change
Operating Cash Flow	$-79.4M	↓ 12.84%
Investing Cash Flow	$-41.8M	↑ 1.21%
Financing Cash Flow	$310.8M	↑ 112.01%

	FY21	Y/Y Change
Operating Cash Flow	$102.5M	↓ 229.09%
Investing Cash Flow	$36.9M	↓ 188.28%
Financing Cash Flow	$-181.5M	↓ 158.4%

	FY22	Y/Y Change
Operating Cash Flow	$69.9M	↓ 31.8%
Investing Cash Flow	$-38.4M	↓ 204.07%
Financing Cash Flow	$280.1M	↓ 254.33%

	FY23	Y/Y Change
Operating Cash Flow	$74.9M	↑ 7.17%
Investing Cash Flow	$-40.3M	↑ 5.03%
Financing Cash Flow	$21.5M	↓ 92.33%

	FY24	Y/Y Change
Operating Cash Flow	$183.0M	↑ 144.33%
Investing Cash Flow	$-48.2M	↑ 19.41%
Financing Cash Flow	$18.6M	↓ 13.65%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$10.0M	↓ 81.5%
Investing Cash Flow	$-6.4M	↓ 47.58%
Financing Cash Flow	$37.1M	↓ 840.28%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$43.4M	↑ 334.39%
Investing Cash Flow	$-12.6M	↑ 97.53%
Financing Cash Flow	$-11.9M	↓ 131.95%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$51.0M	↑ 17.62%
Investing Cash Flow	$-18.5M	↑ 47.35%
Financing Cash Flow	$-3.3M	↓ 72.35%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$78.7M	↑ 54.35%
Investing Cash Flow	$-10.7M	↓ 42.18%
Financing Cash Flow	$-3.4M	↑ 4.94%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$24.0M	↓ 69.55%
Investing Cash Flow	$-10.6M	↓ 0.75%
Financing Cash Flow	$-4.4M	↑ 28.37%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$62.9M	↑ 162.54%
Investing Cash Flow	$-9.0M	↓ 15.62%
Financing Cash Flow	$-209.0M	↑ 4627.03%

Livanova Plc Technicals Summary

Sell

Neutral

Buy

Livanova Plc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Livanova Plc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Livanova Plc	27.27%	14.68%	17.59%	-14.5%	11.7%
Medtronic Plc	2.78%	6.91%	8.77%	-3.04%	-9.66%
Edwards Lifesciences Corp.	2.66%	3.35%	13.47%	-22.21%	-0.3%
Boston Scientific Corp.	-0.46%	-1.12%	33.12%	145.51%	164.73%
Stryker Corporation	-2.65%	-1.82%	12.04%	70.97%	100.28%
Abbott Laboratories	-1.82%	-0.65%	16.52%	17.0%	28.43%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Livanova Plc	31.72	NA	0.7	3.76	-0.18	0.05	NA	20.57
Medtronic Plc	25.51	25.51	2.16	5.46	0.1	0.04	0.03	37.46
Edwards Lifesciences Corp.	32.71	32.71	4.64	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	61.01	61.01	1.78	2.98	0.12	0.05	NA	15.14
Stryker Corporation	50.26	50.26	2.16	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.24	16.24	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Livanova Plc	Buy	$2.9B	11.7%	31.72	-16.14%
Medtronic Plc	Buy	$118.0B	-9.66%	25.51	13.9%
Edwards Lifesciences Corp.	Buy	$45.9B	-0.3%	32.71	72.96%
Boston Scientific Corp.	Buy	$151.9B	164.73%	61.01	13.55%
Stryker Corporation	Buy	$144.9B	100.28%	50.26	12.25%
Abbott Laboratories	Buy	$225.2B	28.43%	16.24	32.43%

About Livanova Plc

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; and devices that deliver neuromodulation therapy for treating difficult-to-treat depression and drug-resistant epilepsy. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Organization	Livanova Plc
Employees	2900
CEO	Mr. Vladimir A. Makatsaria
Industry	Health Technology

Key Management of Livanova Plc

Name	Title
Mr. Vladimir A. Makatsaria	CEO & Director
Mr. Alex Shvartsburg C.M.A.	Chief Financial Officer
Mr. Michael D. Hutchinson	Senior VP, Chief Legal Officer & Company Secretary
Mr. Ahmet Tezel Ph.D.	Chief Innovation Officer
Mr. Franco Poletti	President of Cardiopulmonary Business Unit
Ms. Lindsey Little	Senior Director of Investor Relations
Deanna Wilke	Vice President of Corporate Communications
Mr. Philip Kowalczyk	Chief Strategy & Corporate Development Officer
Ms. Natalia Kozmina	Chief Human Resources Officer
Mr. Paul R. Buckman	President of Advanced Circulatory Support & GM of Transcatheter Mitral Valve Replacement

Important FAQs about investing in LIVN Stock from India :

What is Livanova Plc share price today?

Livanova Plc share price today is $53.74 as on August 16, 2025 at 1:29 AM IST at the close of the market. Livanova Plc share today touched a day high of $54.25 and a low of $53.68.

What is the 52 week high and 52 week low for Livanova Plc share?

Livanova Plc share touched a 52 week high of $57.35 and a 52 week low of $32.48. Livanova Plc stock price today, August 16, 2025 at 1:29 AM IST is trending at $53.74, lower by 6.29% versus the 52 week high.

How to invest in Livanova Plc Stock (LIVN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Livanova Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Livanova Plc Shares that will get you 0.0279 shares as per Livanova Plc share price of $53.74 per share as on August 16, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Livanova Plc Stock (LIVN) from India?

Indian investors can start investing in Livanova Plc (LIVN) shares with as little as ₹87.492 or $1 (as of August 16, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹874.92 in Livanova Plc stock (as per the Rupee-Dollar exchange rate as on August 16, 2025). Based on Livanova Plc share’s latest price of $53.74 as on August 16, 2025 at 1:29 AM IST, you will get 0.1861 shares of Livanova Plc. Learn more about fractional shares .

What are the returns that Livanova Plc has given to Indian investors in the last 5 years?

Livanova Plc stock has given 11.7% share price returns and 16.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?